Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
26.41
-0.25 (-0.94%)
At close: Mar 9, 2026, 4:00 PM EDT
25.90
-0.51 (-1.93%)
After-hours: Mar 9, 2026, 7:21 PM EDT
Immunovant Balance Sheet
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 994.53 | 713.97 | 635.37 | 376.53 | 493.82 | 400.15 | Upgrade
|
| Cash & Short-Term Investments | 994.53 | 713.97 | 635.37 | 376.53 | 493.82 | 400.15 | Upgrade
|
| Cash Growth | 165.43% | 12.37% | 68.74% | -23.75% | 23.41% | 297.87% | Upgrade
|
| Accounts Receivable | - | 2.08 | 5.34 | 0.7 | 12.23 | 0.6 | Upgrade
|
| Other Receivables | 1.64 | 0.43 | 0.17 | 0.19 | 0.63 | 0.55 | Upgrade
|
| Receivables | 1.64 | 2.51 | 5.5 | 0.89 | 12.86 | 1.14 | Upgrade
|
| Prepaid Expenses | 46.77 | 51.18 | 24.9 | 26.92 | 6.25 | 7.72 | Upgrade
|
| Total Current Assets | 1,043 | 767.66 | 665.77 | 404.33 | 512.93 | 409.01 | Upgrade
|
| Property, Plant & Equipment | 0.53 | 0.94 | 0.6 | 1.51 | 2.63 | 3.48 | Upgrade
|
| Other Long-Term Assets | 8.92 | 7.62 | - | - | - | - | Upgrade
|
| Total Assets | 1,052 | 776.22 | 666.37 | 405.84 | 515.56 | 412.49 | Upgrade
|
| Accounts Payable | 8.62 | 17.66 | 7.16 | 1.35 | 18.63 | 2.43 | Upgrade
|
| Accrued Expenses | 57.64 | 50.75 | 41.3 | 40.42 | 24.58 | 15.16 | Upgrade
|
| Current Portion of Leases | - | 0.1 | 0.14 | 1.17 | 1.15 | 1.18 | Upgrade
|
| Other Current Liabilities | - | 0.27 | 0.02 | 0.35 | 0.17 | - | Upgrade
|
| Total Current Liabilities | 66.26 | 68.78 | 48.61 | 43.3 | 44.52 | 18.77 | Upgrade
|
| Long-Term Leases | - | - | - | 0.05 | 1.22 | 2.24 | Upgrade
|
| Total Liabilities | 66.26 | 68.78 | 48.61 | 43.34 | 45.74 | 21.01 | Upgrade
|
| Common Stock | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 2,582 | 1,945 | 1,442 | 927.98 | 824.8 | 590.43 | Upgrade
|
| Retained Earnings | -1,597 | -1,240 | -825.68 | -566.35 | -355.39 | -198.66 | Upgrade
|
| Comprehensive Income & Other | 1.2 | 1.46 | 1.91 | 0.85 | 0.4 | -0.3 | Upgrade
|
| Shareholders' Equity | 986.14 | 707.45 | 617.76 | 362.49 | 469.83 | 391.48 | Upgrade
|
| Total Liabilities & Equity | 1,052 | 776.22 | 666.37 | 405.84 | 515.56 | 412.49 | Upgrade
|
| Total Debt | - | 0.1 | 0.14 | 1.22 | 2.36 | 3.42 | Upgrade
|
| Net Cash (Debt) | 994.53 | 713.87 | 635.23 | 375.31 | 491.45 | 396.73 | Upgrade
|
| Net Cash Growth | 165.45% | 12.38% | 69.25% | -23.63% | 23.88% | 307.40% | Upgrade
|
| Net Cash Per Share | 5.74 | 4.71 | 4.60 | 3.05 | 4.48 | 4.52 | Upgrade
|
| Filing Date Shares Outstanding | 203.53 | 170.92 | 146.05 | 130.41 | 116.51 | 97.98 | Upgrade
|
| Total Common Shares Outstanding | 203.32 | 170.11 | 145.58 | 130.33 | 116.48 | 97.97 | Upgrade
|
| Working Capital | 976.68 | 698.89 | 617.16 | 361.04 | 468.41 | 390.24 | Upgrade
|
| Book Value Per Share | 4.85 | 4.16 | 4.24 | 2.78 | 4.03 | 4.00 | Upgrade
|
| Tangible Book Value | 986.14 | 707.45 | 617.76 | 362.49 | 469.83 | 391.48 | Upgrade
|
| Tangible Book Value Per Share | 4.85 | 4.16 | 4.24 | 2.78 | 4.03 | 4.00 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.